Hyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats

Kahraman C., YAMAN H.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.3, pp.1572-1578, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.3906/sag-2011-76
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1572-1578
  • Keywords: Adiponectin, insulin, insulin sensitivity, resistin, plasminogen activator inhibitor-I, HIGH-DENSITY-LIPOPROTEIN, CORONARY-HEART-DISEASE, ADIPOSE-TISSUE, GLUCOSE, CHOLESTEROL, OBESITY, RISK, MEN
  • Karadeniz Technical University Affiliated: Yes

Abstract

Background/aim: Hyperbaric oxygen therapy (HBOT) causes insulin sensitivity, but the reason for this is not known yet. The aim of the present study was to investigate the effect of HBOT on insulin sensitivity via resistin, plasminogen activator inhibitor-I (PAI-I), and adiponectin.